Gene · 2175
Papers3,803
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
741 to 760 of 3,803
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Methylation Analyses Reveal Promoter Hypermethylation as a Rare Cause of "Second Hit" in Germline BRCA1-Associated Pancreatic Ductal Adenocarcinoma. | Mol Diagn Ther | 2022 | 36178671 | PubTator, text mining | PubMed |
| Applications for open access normalized synthesis in metastatic prostate cancer trials. | Front Artif Intell | 2022 | 36171797 | PubTator, text mining | PubMed |
| Polyclonal evolution of Fanconi anemia to MDS and AML revealed at single cell resolution. | Exp Hematol Oncol | 2022 | 36167633 | PubTator, text mining | PubMed |
| Mechanisms of development and progression of pancreatic neoplasms. | Pathol Int | 2022 | 36161420 | PubTator, text mining | PubMed |
| A homozygous PIWIL2 frameshift variant affects the formation and maintenance of human-induced pluripotent stem cell-derived spermatogonial stem cells and causes Sertoli cell-only syndrome. | Stem Cell Res Ther | 2022 | 36153567 | PubTator, text mining | PubMed |
| Quantitative gait analysis in mild cognitive impairment, dementia, and cognitively intact individuals: a cross-sectional case-control study. | BMC Geriatr | 2022 | 36151524 | PubTator, text mining | PubMed |
| Structure-Based Discovery of Negative Allosteric Modulators of the Metabotropic Glutamate Receptor 5. | ACS Chem Biol | 2022 | 36149353 | PubTator, text mining | PubMed |
| Neuromorphic Tactile Edge Orientation Classification in an Unsupervised Spiking Neural Network. | Sensors (Basel) | 2022 | 36146344 | PubTator, text mining | PubMed |
| MC180295 Inhibited Epstein-Barr Virus-Associated Gastric Carcinoma Cell Growth by Suppressing DNA Repair and the Cell Cycle. | Int J Mol Sci | 2022 | 36142506 | PubTator, text mining | PubMed |
| Clinical Significance of Germline Pathogenic Variants among 51 Cancer Predisposition Genes in an Unselected Cohort of Italian Pancreatic Cancer Patients. | Cancers (Basel) | 2022 | 36139606 | PubTator, text mining | PubMed |
| Androgen Receptor Splice Variants Contribute to the Upregulation of DNA Repair in Prostate Cancer. | Cancers (Basel) | 2022 | 36139600 | PubTator, text mining | PubMed |
| The Biological and Clinical Consequences of RNA Splicing Factor U2AF1 Mutation in Myeloid Malignancies. | Cancers (Basel) | 2022 | 36139566 | PubTator, text mining | PubMed |
| Exome sequencing efficacy and phenotypic expansions involving esophageal atresia/tracheoesophageal fistula plus. | Am J Med Genet A | 2022 | 36135330 | PubTator, text mining | PubMed |
| What can we learn from more than 1,000 Brazilian patients at risk of hereditary cancer? | Front Oncol | 2022 | 36132150 | PubTator, text mining | PubMed |
Adaptive transcriptomic and immune infiltrate responses in the tumor immune microenvironment following neoadjuvant chemotherapy in high grade serous ovarian cancer reveal novel prognostic associations and activation of pro-tumorigenic pathways. | Front Immunol | 2022 | 36131935 | PubTator, text mining | PubMed |
| Emerging tyrosine kinase inhibitors for head and neck cancer. | Expert Opin Emerg Drugs | 2022 | 36131561 | PubTator, text mining | PubMed |
| Failure of human rhombic lip differentiation underlies medulloblastoma formation. | Nature | 2022 | 36131014 | PubTator, text mining | PubMed |
| Talazoparib, a Poly(ADP-ribose) Polymerase Inhibitor, for Metastatic Castration-resistant Prostate Cancer and DNA Damage Response Alterations: TALAPRO-1 Safety Analyses. | Oncologist | 2022 | 36124924 | PubTator, text mining | PubMed |
| KRAS Mutation Variants and Co-occurring PI3K Pathway Alterations Impact Survival for Patients with Pancreatic Ductal Adenocarcinomas. | Oncologist | 2022 | 36124727 | PubTator, text mining | PubMed |
| Characterization of genetic predisposition to molecular subtypes of breast cancer in Brazilian patients. | Front Oncol | 2022 | 36119527 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2175/papers?page=38